DRKS00000787Active, not recruitingNot Applicable
aserenucleation of Prostate Glands > 60g - ThuVEP vs. HoLEP
Asklepios Klinik BarmbekAbteilung für Urologie0 sites120 target enrollmentStarted: May 16, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- Male
Inclusion Criteria
- •IPSS-Score = 8
- •Uroflow: Qmax = 15ml/s
- •Urodynamic: Schäfer-Scale = II°
- •Prostate volume measured by transrectal ultrasoundl (TRUS) = 60 ml
Exclusion Criteria
- •Known urethral or prostate surgery
- •Voiding symptoms not referred to BPO (Striktur)
- •Known Prostate Cancer
- •Neurogenic Bladder
Investigators
Similar Trials
Completed
Not Applicable
Prostate volume measurement by the general practitionerprostate carcinoma1003859710036958Prostate cancerNL-OMON41082Erasmus MC, Universitair Medisch Centrum Rotterdam116
Recruiting
Phase 2
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pre-operative Lymph Node Assessment in Intermediate and High-risk Nonmetastasic Prostate CancerProstate Cancer2024-516319-25-00Centre Hospitalier Regional Et Universitaire De Brest159
Completed
Not Applicable
aser enucleation of the prostate for benign prostatic hyperplasiaN40Hyperplasia of prostateDRKS00008206Asklepios Klinik Barmbek110
Recruiting
Not Applicable
SEMINAL VESICLE MOTION RELATIVE TO THE PROSTATEprostate carcinoma1003858810036958prostate cancerNL-OMON30118Erasmus MC, Universitair Medisch Centrum Rotterdam20
Completed
Not Applicable
Prostate and urethral dosimetry in high dose rate brachytherapy for prostate cancerMeasument of prostatic tissue and urethral doses in HDR brachytherapy for prostate cancerJPRN-UMIN000005123Kawasaki Medical School10